Prevnar 13 Drug Interactions
Links shared publicly online about this topic.
- 835total visits
Prevnar 13 Drug Interactions
View full resource at kids.emedtv.com
Tags: Pneumococcal Vaccine, Drug, Anti-Clotting Medication, Anticoagulant, Vaccine, Prevnar, Coumadin
Most Recently Shared on October 1, 2010 at 1:09 am By:
Just added http://bit.ly/cy9yTX to the Prevnar 13 Drug Interactions WisdomCard http://bit.ly/b9xwUk @organizedwisdom
Drug Interactions Significantly Reduce Targeted Therapy Efficacy
onclive.com — “The DDIs between Co-Rx medications and targeted OAD is associated with a significant decrease in effectiveness and increased toxicity.” View full resource at onclive.com
Most Recently Shared on March 16, 2012 at 9:42 pm By:
Co-Rx and targeted OAD interactions are associated with a significant decrease in effectiveness and increased toxicity http://t.co/EMiQ7jpp
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's - Yahoo! Finance UK
uk.finance.yahoo.com — “Read 'UPDATE 1-Pfizer says its drug is best hope for Alzheimer's' on Yahoo! Finance UK. * Says prior trials suggest edge over Lilly Alzheimer's drug * Says Prevnar 13 pneumonia data expected by 2013 * Expects FDA panel to review arthritis drug (Adds quotes from research chief, details on ...” View full resource at uk.finance.yahoo.com
Most Recently Shared on February 14, 2012 at 7:37 pm By:
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's: * Says prior trials suggest edge over Lilly Alzheime... http://t.co/I53zjiUn
News in Brief: Week of Jan. 2-6 -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “This roundup includes the following news briefs: Similarity in Drug Names Poses Serious Injury Risk, Says FDA; FDA Votes to Expand Prevnar 13 Indication; PCMHs, Physician-led Networks Generate Savings for N.C. Medicaid Program; HHS Awards Bonuses for State Medicaid, CHIP Program Expansions; and CHFM Seeks Fellowship Applicants.” View full resource at aafp.org
Most Recently Shared on January 6, 2012 at 1:36 am By:
News in Brief: Week of Jan. 2-6 http://t.co/9a7vkaXB
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults
news-medical.net — “Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the Company's pneumococcal conjugate vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults.” View full resource at news-medical.net
Most Recently Shared on December 31, 2011 at 9:55 am By:
Meningitis News: FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults: Pf... http://t.co/4eorFS2i
Additional Data From Pfizer's Prevnar 13 Clinical Trials In Adults 50 Years And Older To Be Presented At The 49th Annual Meeting Of The Infectious Diseases Society Of America - Drugs.com MedNews
drugs.com — “Oct 21, 2011 - Pfizer Inc. (NYSE PFE) announced today that additional data from several clinical studies of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine” View full resource at drugs.com
Most Recently Shared on October 21, 2011 at 3:15 pm By:
Drugs and Devices OW OW Health
Additional Data From Pfizer's Prevnar 13 Clinical Trials In Adults 50 Years And Older To Be Presented At T... http://t.co/IqxTuLlB #drug
FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults
news-medical.net — “Pfizer Inc today announced that the U.S. Food and Drug Administration (FDA) has issued a 90-day extension to the action date for the Company's supplemental Biologics License Application (sBLA) for use of Prevnar 13, in adults aged 50 and older.” View full resource at news-medical.net
Most Recently Shared on July 30, 2011 at 1:59 pm By:
Meningitis News: FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults: Pfizer I... http://bit.ly/ojN4b7
FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults
news-medical.net — “Pfizer Inc today announced that the U.S. Food and Drug Administration (FDA) has issued a 90-day extension to the action date for the Company's supplemental Biologics License Application (sBLA) for use of Prevnar 13, in adults aged 50 and older.” View full resource at news-medical.net
Most Recently Shared on July 30, 2011 at 7:43 am By:
FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults: Pfizer Inc today announce... http://bit.ly/qx8Dmp
Data Mining Approach Shows Promise in Detecting Unexpected Drug Interactions, July 13, 2011, Hampton 306 (2): 144 — JAMA
jama.ama-assn.org — “Data Mining Approach Shows Promise in Detecting Unexpected Drug Interactions, July 13, 2011, Hampton 306 (2): 144 — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on July 13, 2011 at 5:33 pm By:
Perficient Health IT Health Business
#DataMining Approach Shows Promise in Detecting Unexpected Drug Interactions http://bit.ly/ofbeRa #analytics #BigData #HealthIT #HITsm
Little Support for GOP Plan to Privatize Medicare: Poll - Drugs.com MedNews
drugs.com — “Respondents to Harris Interactive HealthDay survey suggest lowering fees paid to drug companies, hospitals and doctors NORWALK, Conn., June 13, 2011 A new poll” View full resource at drugs.com
Most Recently Shared on June 13, 2011 at 8:13 pm By:
Drugs and Devices OW OW Health
Little Support for GOP Plan to Privatize Medicare: Poll: Respondents to Harris Interactive/HealthDay surve... http://bit.ly/mi6O3J #drug
Study: Faulty Pharmacy Alert Systems Missing Risky Drug Interactions - iHealthBeat
ihealthbeat.org — “A University of Arizona study of 64 state pharmacies finds that many clinical decision support systems used to detect potentially dangerous drug combinations are flawed. Researchers discovered that only 28 pharmacies accurately identified 13 risky drug combinations. Arizona Republic.” View full resource at ihealthbeat.org
Most Recently Shared on June 1, 2011 at 6:27 pm By:
iHealthBeat.org Health Organization
Study: Faulty Pharmacy Alert Systems Missing Risky Drug Interactions - http://bit.ly/jM9Qvj
Pfizer’s Vaccine Plan - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “In five years, Wall Street forecasters agree that Prevnar 13, the vaccine against pneumonia and other infections caused by the pneumococcocus bacteria, will be Pfizer's biggest seller, generating $6 billion in annual sales. Most of those revenues are expected to come from the use of the $400-per-course vaccine [...]” View full resource at blogs.forbes.com
Most Recently Shared on May 9, 2011 at 5:06 pm By:
Drugs and Devices OW OW Health
Pfizer's Vaccine Plan: How Prevnar 13 could become a big seller in adults. http://onforb.es/jTl1sb #drug
Pfizer R&D chief upbeat despite smaller budget | Reuters
reuters.com — “NEW YORK (Reuters) - Pfizer Inc still has enough resources to innovate and support its experimental medicines despite the drugmaker's recent decision to cut its massive research budget, Pfizer's” View full resource at reuters.com
Most Recently Shared on April 1, 2011 at 10:40 am By:
John Carroll Health Communicator
Pfizer's R&D chief Dolsten ticks off top drug prospects: tofacitinib, crizotinib and adult Prevnar 13. http://reut.rs/fW4GTs
Half of Americans polled don't think vaccines cause autism - - Drug Topics
drugtopics.modernmedicine.com — “Half of Americans polled don't think vaccines cause autism. However, 18% are convinced that vaccines, like the MMR vaccine, can cause the disorder, and another 30% aren't sure, according to a new Harris Interactive/HealthDay poll.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on January 28, 2011 at 6:24 am By:
Drugs and Devices OW OW Health
Half of Americans polled don't think vaccines cause autism: . However, 18% are convinced that vaccines, like t... http://bit.ly/g13dx0
Hepatitis C New Drug Research
hepatitiscnewdrugresearch.com — “Currently displaying 13 drugs known to have a major interaction with peginterferon alfa-2a.” View full resource at hepatitiscnewdrugresearch.com
Most Recently Shared on December 27, 2010 at 12:05 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Hepatitis C New Drug Research: Peginterferon alfa-2a List Of Drug Interactions With http://t.co/wKQT6Kj
Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease
news-medical.net — “Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.” View full resource at news-medical.net
Most Recently Shared on December 23, 2010 at 10:36 am By:
Meningitis News: Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease: Pfiz... http://bit.ly/eq2rKO
Advertisement
